Pregnancy and Birth

ACOG strongly recommends COVID-19, RSV, and flu vaccines for pregnant patients ahead of the 2026–27 respiratory season.

A recap of the top stories from August 2026 in women's health.

Missed the rollout of ACOG's 2026 Maternal Immunization Schedule? This FAQ breaks down everything clinicians need to know about the new guidance.

Alexis Totaro, MSN, RN, WHNP-c, CARN-AP, outlines the criteria guiding the choice between outpatient counseling and emergency psychiatric care in the postpartum period.

Alexis Totaro, MSN, RN, WHNP-c, CARN-AP, explains how sleep behavior helps distinguish normal postpartum deprivation from an emerging psychiatric concern, and how to screen for psychosis.

Alexis Totaro, MSN, RN, WHNP-c, CARN-AP, explains that the clinical exam and knowledge of a patient's baseline are essential to catching early signs of postpartum psychosis and depression.

With brexanolone withdrawn in 2025, zuranolone leads PPD treatment as luvesilocin and LPCN 1154 advance in trials.

A new study finds a 14.9% recurrence risk for severe hypertensive disorders of pregnancy.

A new study finds cesarean delivery occurred in 42.5% of pregnancies with a life-limiting fetal diagnosis.

Rachel Meislin, MD, explains that anti-inflammatory reliever and maintenance strategies are standard in pulmonology and ob-gyns should recognize rather than disrupt them.

Rachel Meislin, MD, describes a structured asthma assessment that evaluates comorbidities, triggers, and adherence together.

A 20-year PMSS analysis identifies cardiovascular conditions as the leading cause of pregnancy-related death.

Rachel Meislin, MD, explains that uncontrolled asthma, not its diagnosis or treatment, drives adverse pregnancy outcomes, framing disease control as a fetal-protective strategy.

Over 27% of OUD pregnancies had no HCV testing, and only 9.7% with active infection received postpartum DAAs.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

Mark N. Simon, MD, MMM, discusses the clinical risks tied to maternity care deserts and longer travel times following new March of Dimes data.

Liz Miracle, PT, MPT, WCS, argues that ACOG Committee Opinion No. 736, which supports non-office postpartum assessment, applies equally to virtual pelvic floor physical therapy.

Included are statements from SMFM, ACOG, and the AAP.

One in 3 counties in the United States remain maternity care deserts as 96 L&D closures compound access gaps, per March of Dimes.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

A University of Michigan pilot study, discussed here by lead researcher Alex F. Peahl, MD, MSc, found patient-operated remote ultrasonography feasible for completing biophysical profiles in high-risk pregnancies.

One in 3 FQHCs lack on-site prenatal care, with gaps concentrated in maternity deserts, a national study finds.

Joy Baker, MD, FACOG, explains how zuranolone's rapid onset gives clinicians a meaningfully different counseling conversation for PPD.

A cohort study of 15,382 mother-infant dyads found that subfecundity was independently associated with elevated autism spectrum disorder odds and behavioral problem scores in offspring, while IVF treatment showed no significant neurodevelopmental associations.

Corresponding author Cynthia Gyamfi-Bannerman, MD, MS, says late preterm hypoglycemia did not adversely affect neurodevelopment.